The Knoxville Community Development Corporation broke ground on Phase 2 of the Transforming Western initiative, which will add 52 housing units, a town center, a police substation, and a health ...

“As we continue to evaluate findings from our Phase 2 OVATION 2 Study, the data show consistently strong improvement in overall and progression-free survival, suggesting that IMNN-001 may drive ...

Confirmation of size and scope of Phase 3 clinical program and associated safety database to support proposed indication in knee osteoarthritis Confirmation of pivotal study design, including ...

Raoul Pal says we’re now in “Phase 2” of crypto’s explosive growth cycle, potentially heading toward a $100 trillion market cap. Ready to turn the market’s comeback into steady cash flow?

today announced the first patient has been dosed in the Phase 2, investigator-initiated OASIS trial to evaluate TNX-102 SL in reducing the severity of acute stress reaction (ASR) and the frequency ...

Nate Wiggins Discusses His Year 2 Goals, Best Matchup From His First Season, And How He's Becoming a Better Pro Ravens CB Nate Wiggins joins team insiders Ryan Mink and Garrett Downing to talk ...

The mean reduction in GGO score from baseline to Week 24 was greater in the molgramostim group (n=78) than in the placebo group (n=79) (-2.1 vs. -1.1; P=0.0004) Fewer patients in the molgramostim ...

Phase 2 of the Wuthering Waves 2.3 update officially kicked off on May 22, 2025, and it features several Resonators. Ciaccona is the newest entry to the playable roster – she hails from the Aero ...

PHASE 2 is an American graffiti artist known for his pioneering role in the “bubble letter” style of spray painting. Born Michael Lawrence Marrow on August 2, 1955, in Bronx, NY, he began tagging ...

Armata Pharmaceuticals has posted early validation of its phage platform. The phase 1b/2a trial linked a bacteriophage cocktail to improved outcomes in patients with bacteria in their blood ...

Transforming Western will be done in four phases. The first and second have already begun. The third phase is expected to be ...

Actuate's Phase 2 trial shows elraglusib/GnP improves overall survival in mPDAC patients, with a 37% lower death risk. Actuate Therapeutics presented promising results from its Phase 2 trial ...